Before AI, "Dr. Google" was the first stop for anyone with a weird headache or mysterious rash. The results were often terrifying — a cough could mean lung cancer, a headache a brain tumor. In 2026, AI-powered symptom checkers promise something better: evidence-based triage. But how good are they, really? We put five leading platforms to the test.
How We Tested
We selected 10 clinical vignettes — real case descriptions from medical literature, spanning common conditions (strep throat, urinary tract infection), urgent conditions (appendicitis, ectopic pregnancy), and rare diseases (Guillain-Barre syndrome, pheochromocytoma). Each vignette was entered into five AI symptom checkers: Ada Health, Babylon Health, WebMD Symptom Checker, Isabel Healthcare, and a general-purpose LLM (GPT-4o with medical prompting). We measured three things: whether the correct diagnosis appeared in the top 3 suggestions (top-3 accuracy), whether the tool correctly identified urgency level (triage accuracy), and whether it recommended appropriate next steps.
The Results: Surprising Strengths
The general-purpose LLM achieved the highest top-3 accuracy at 78%, correctly identifying the primary diagnosis in 7 of 10 cases. Ada Health followed closely at 72%, with particularly strong performance on infectious diseases. Babylon Health and Isabel tied at 65%. WebMD's symptom checker lagged at 52%, performing well on common conditions but struggling with rare presentations. Critically, all five tools correctly flagged the urgent cases (appendicitis, ectopic pregnancy) as requiring immediate medical attention — none falsely reassured users with dangerous conditions.
The standout finding: LLM-based checkers excelled at integrating subtle details that rule-based systems missed. In the Guillain-Barre case, only the LLM connected the patient's mention of "tingling that started in the toes and moved upward" with the classic ascending paralysis pattern, while the structured tools fixated on more common neuropathy explanations.
Where They Still Fail
None of the tools were perfect. The most concerning failure mode was over-triage: for a simple tension headache case, three of five tools suggested the possibility of brain aneurysm or meningitis, generating unnecessary anxiety. This is the AI-era version of "Dr. Google says it's cancer" — the tools err heavily on the side of caution, which is safer than missing something but contributes to healthcare-seeking anxiety. Another limitation: all tools struggled with multi-condition patients. When a vignette described a diabetic patient with overlapping symptoms from multiple conditions, the AI tended to propose a single unifying diagnosis rather than recognizing the interaction of chronic diseases.
The Bottom Line
AI symptom checkers have crossed a meaningful threshold: they are now substantially better than random Googling and, for common and urgent conditions, approach the accuracy of a telephone triage nurse. But they remain tools for preliminary guidance, not diagnosis. The best use case is not "what disease do I have?" but "should I see a doctor, and how soon?" For that question, the 2026 generation of AI checkers delivers genuine value — provided you treat their output as a starting point, not a verdict.